nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C19—Teniposide—lymphatic system cancer	0.144	0.261	CbGbCtD
Fosphenytoin—CYP2C9—Teniposide—lymphatic system cancer	0.12	0.217	CbGbCtD
Fosphenytoin—CYP3A4—Cytarabine—lymphatic system cancer	0.0706	0.128	CbGbCtD
Fosphenytoin—CYP3A4—Teniposide—lymphatic system cancer	0.0696	0.126	CbGbCtD
Fosphenytoin—ALB—Methotrexate—lymphatic system cancer	0.0647	0.117	CbGbCtD
Fosphenytoin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0486	0.0884	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—lymphatic system cancer	0.0335	0.0608	CbGbCtD
Fosphenytoin—Pneumonia—Carmustine—lymphatic system cancer	0.00108	0.0024	CcSEcCtD
Fosphenytoin—Confusional state—Fludarabine—lymphatic system cancer	0.00108	0.00239	CcSEcCtD
Fosphenytoin—Dysuria—Vincristine—lymphatic system cancer	0.00107	0.00239	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00107	0.00238	CcSEcCtD
Fosphenytoin—Infection—Fludarabine—lymphatic system cancer	0.00106	0.00236	CcSEcCtD
Fosphenytoin—Decreased appetite—Teniposide—lymphatic system cancer	0.00106	0.00235	CcSEcCtD
Fosphenytoin—Renal failure—Carmustine—lymphatic system cancer	0.00105	0.00234	CcSEcCtD
Fosphenytoin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00105	0.00233	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00105	0.00233	CcSEcCtD
Fosphenytoin—Apnoea—Methotrexate—lymphatic system cancer	0.00105	0.00233	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00105	0.00233	CcSEcCtD
Fosphenytoin—Rash—Mechlorethamine—lymphatic system cancer	0.00104	0.00231	CcSEcCtD
Fosphenytoin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00104	0.00231	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00103	0.0023	CcSEcCtD
Fosphenytoin—Speech disorder—Methotrexate—lymphatic system cancer	0.00103	0.00229	CcSEcCtD
Fosphenytoin—Pneumonia—Vincristine—lymphatic system cancer	0.00103	0.00229	CcSEcCtD
Fosphenytoin—Anorexia—Fludarabine—lymphatic system cancer	0.00102	0.00226	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00101	0.00224	CcSEcCtD
Fosphenytoin—Pneumonia—Mitoxantrone—lymphatic system cancer	0.001	0.00223	CcSEcCtD
Fosphenytoin—Feeling abnormal—Teniposide—lymphatic system cancer	0.001	0.00223	CcSEcCtD
Fosphenytoin—Chills—Bleomycin—lymphatic system cancer	0.000989	0.0022	CcSEcCtD
Fosphenytoin—Skin discolouration—Methotrexate—lymphatic system cancer	0.000982	0.00218	CcSEcCtD
Fosphenytoin—Sweating—Vincristine—lymphatic system cancer	0.000981	0.00218	CcSEcCtD
Fosphenytoin—Renal failure—Mitoxantrone—lymphatic system cancer	0.000979	0.00218	CcSEcCtD
Fosphenytoin—Nausea—Mechlorethamine—lymphatic system cancer	0.000979	0.00218	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000973	0.00216	CcSEcCtD
Fosphenytoin—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000968	0.00215	CcSEcCtD
Fosphenytoin—Urticaria—Teniposide—lymphatic system cancer	0.000965	0.00215	CcSEcCtD
Fosphenytoin—Oliguria—Methotrexate—lymphatic system cancer	0.000963	0.00214	CcSEcCtD
Fosphenytoin—Body temperature increased—Teniposide—lymphatic system cancer	0.00096	0.00214	CcSEcCtD
Fosphenytoin—Paraesthesia—Fludarabine—lymphatic system cancer	0.000959	0.00213	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000957	0.00213	CcSEcCtD
Fosphenytoin—Sweating—Mitoxantrone—lymphatic system cancer	0.000955	0.00212	CcSEcCtD
Fosphenytoin—Dyspnoea—Fludarabine—lymphatic system cancer	0.000952	0.00212	CcSEcCtD
Fosphenytoin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00094	0.00209	CcSEcCtD
Fosphenytoin—Dysarthria—Methotrexate—lymphatic system cancer	0.000938	0.00209	CcSEcCtD
Fosphenytoin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000934	0.00208	CcSEcCtD
Fosphenytoin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000928	0.00206	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000914	0.00203	CcSEcCtD
Fosphenytoin—Constipation—Fludarabine—lymphatic system cancer	0.000913	0.00203	CcSEcCtD
Fosphenytoin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00091	0.00202	CcSEcCtD
Fosphenytoin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000896	0.00199	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00089	0.00198	CcSEcCtD
Fosphenytoin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000887	0.00197	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000887	0.00197	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000887	0.00197	CcSEcCtD
Fosphenytoin—Anaemia—Bleomycin—lymphatic system cancer	0.000887	0.00197	CcSEcCtD
Fosphenytoin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00088	0.00196	CcSEcCtD
Fosphenytoin—Asthenia—Teniposide—lymphatic system cancer	0.000872	0.00194	CcSEcCtD
Fosphenytoin—Malaise—Bleomycin—lymphatic system cancer	0.000865	0.00192	CcSEcCtD
Fosphenytoin—Pruritus—Teniposide—lymphatic system cancer	0.00086	0.00191	CcSEcCtD
Fosphenytoin—Leukopenia—Bleomycin—lymphatic system cancer	0.000859	0.00191	CcSEcCtD
Fosphenytoin—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000857	0.00191	CcSEcCtD
Fosphenytoin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000844	0.00188	CcSEcCtD
Fosphenytoin—Vaginal infection—Methotrexate—lymphatic system cancer	0.000838	0.00186	CcSEcCtD
Fosphenytoin—Cough—Bleomycin—lymphatic system cancer	0.000837	0.00186	CcSEcCtD
Fosphenytoin—Diarrhoea—Teniposide—lymphatic system cancer	0.000831	0.00185	CcSEcCtD
Fosphenytoin—Myalgia—Bleomycin—lymphatic system cancer	0.000817	0.00182	CcSEcCtD
Fosphenytoin—Coma—Methotrexate—lymphatic system cancer	0.000811	0.0018	CcSEcCtD
Fosphenytoin—Back pain—Carmustine—lymphatic system cancer	0.00081	0.0018	CcSEcCtD
Fosphenytoin—Discomfort—Bleomycin—lymphatic system cancer	0.000807	0.00179	CcSEcCtD
Fosphenytoin—Chills—Mitoxantrone—lymphatic system cancer	0.000802	0.00178	CcSEcCtD
Fosphenytoin—Ecchymosis—Methotrexate—lymphatic system cancer	0.000802	0.00178	CcSEcCtD
Fosphenytoin—Urine output increased—Methotrexate—lymphatic system cancer	0.000802	0.00178	CcSEcCtD
Fosphenytoin—Confusional state—Bleomycin—lymphatic system cancer	0.000789	0.00176	CcSEcCtD
Fosphenytoin—Tremor—Carmustine—lymphatic system cancer	0.000784	0.00174	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000783	0.00174	CcSEcCtD
Fosphenytoin—Infection—Bleomycin—lymphatic system cancer	0.000778	0.00173	CcSEcCtD
Fosphenytoin—Anaemia—Carmustine—lymphatic system cancer	0.000774	0.00172	CcSEcCtD
Fosphenytoin—Back pain—Vincristine—lymphatic system cancer	0.000773	0.00172	CcSEcCtD
Fosphenytoin—Vomiting—Teniposide—lymphatic system cancer	0.000772	0.00172	CcSEcCtD
Fosphenytoin—Sepsis—Methotrexate—lymphatic system cancer	0.00077	0.00171	CcSEcCtD
Fosphenytoin—Agitation—Carmustine—lymphatic system cancer	0.000769	0.00171	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000766	0.00171	CcSEcCtD
Fosphenytoin—Asthenia—Fludarabine—lymphatic system cancer	0.000766	0.0017	CcSEcCtD
Fosphenytoin—Rash—Teniposide—lymphatic system cancer	0.000766	0.0017	CcSEcCtD
Fosphenytoin—Dermatitis—Teniposide—lymphatic system cancer	0.000765	0.0017	CcSEcCtD
Fosphenytoin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000762	0.0017	CcSEcCtD
Fosphenytoin—Headache—Teniposide—lymphatic system cancer	0.000761	0.00169	CcSEcCtD
Fosphenytoin—Pruritus—Fludarabine—lymphatic system cancer	0.000755	0.00168	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000755	0.00168	CcSEcCtD
Fosphenytoin—Back pain—Mitoxantrone—lymphatic system cancer	0.000753	0.00167	CcSEcCtD
Fosphenytoin—Leukopenia—Carmustine—lymphatic system cancer	0.000749	0.00167	CcSEcCtD
Fosphenytoin—Anorexia—Bleomycin—lymphatic system cancer	0.000746	0.00166	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000744	0.00165	CcSEcCtD
Fosphenytoin—Anaemia—Vincristine—lymphatic system cancer	0.000739	0.00164	CcSEcCtD
Fosphenytoin—Agitation—Vincristine—lymphatic system cancer	0.000735	0.00163	CcSEcCtD
Fosphenytoin—Polyuria—Methotrexate—lymphatic system cancer	0.000733	0.00163	CcSEcCtD
Fosphenytoin—Hypotension—Bleomycin—lymphatic system cancer	0.000732	0.00163	CcSEcCtD
Fosphenytoin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000731	0.00163	CcSEcCtD
Fosphenytoin—Convulsion—Carmustine—lymphatic system cancer	0.000725	0.00161	CcSEcCtD
Fosphenytoin—Hypertension—Carmustine—lymphatic system cancer	0.000723	0.00161	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000722	0.00161	CcSEcCtD
Fosphenytoin—Nausea—Teniposide—lymphatic system cancer	0.000722	0.00161	CcSEcCtD
Fosphenytoin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000719	0.0016	CcSEcCtD
Fosphenytoin—Vertigo—Vincristine—lymphatic system cancer	0.000718	0.0016	CcSEcCtD
Fosphenytoin—Leukopenia—Vincristine—lymphatic system cancer	0.000715	0.00159	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000713	0.00159	CcSEcCtD
Fosphenytoin—Myalgia—Carmustine—lymphatic system cancer	0.000713	0.00159	CcSEcCtD
Fosphenytoin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000703	0.00156	CcSEcCtD
Fosphenytoin—Malaise—Mitoxantrone—lymphatic system cancer	0.000702	0.00156	CcSEcCtD
Fosphenytoin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000698	0.00155	CcSEcCtD
Fosphenytoin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000697	0.00155	CcSEcCtD
Fosphenytoin—Convulsion—Vincristine—lymphatic system cancer	0.000693	0.00154	CcSEcCtD
Fosphenytoin—Hypertension—Vincristine—lymphatic system cancer	0.00069	0.00154	CcSEcCtD
Fosphenytoin—Confusional state—Carmustine—lymphatic system cancer	0.000689	0.00153	CcSEcCtD
Fosphenytoin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000681	0.00151	CcSEcCtD
Fosphenytoin—Myalgia—Vincristine—lymphatic system cancer	0.00068	0.00151	CcSEcCtD
Fosphenytoin—Cough—Mitoxantrone—lymphatic system cancer	0.000679	0.00151	CcSEcCtD
Fosphenytoin—Infection—Carmustine—lymphatic system cancer	0.000679	0.00151	CcSEcCtD
Fosphenytoin—Vomiting—Fludarabine—lymphatic system cancer	0.000679	0.00151	CcSEcCtD
Fosphenytoin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000674	0.0015	CcSEcCtD
Fosphenytoin—Rash—Fludarabine—lymphatic system cancer	0.000673	0.0015	CcSEcCtD
Fosphenytoin—Dermatitis—Fludarabine—lymphatic system cancer	0.000673	0.0015	CcSEcCtD
Fosphenytoin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000672	0.00149	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000669	0.00149	CcSEcCtD
Fosphenytoin—Headache—Fludarabine—lymphatic system cancer	0.000669	0.00149	CcSEcCtD
Fosphenytoin—Tachycardia—Carmustine—lymphatic system cancer	0.000667	0.00148	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000665	0.00148	CcSEcCtD
Fosphenytoin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000663	0.00147	CcSEcCtD
Fosphenytoin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000663	0.00147	CcSEcCtD
Fosphenytoin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000655	0.00146	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000652	0.00145	CcSEcCtD
Fosphenytoin—Anorexia—Carmustine—lymphatic system cancer	0.000651	0.00145	CcSEcCtD
Fosphenytoin—Infection—Vincristine—lymphatic system cancer	0.000648	0.00144	CcSEcCtD
Fosphenytoin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000645	0.00144	CcSEcCtD
Fosphenytoin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000644	0.00143	CcSEcCtD
Fosphenytoin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000641	0.00142	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000639	0.00142	CcSEcCtD
Fosphenytoin—Hypotension—Carmustine—lymphatic system cancer	0.000639	0.00142	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000635	0.00141	CcSEcCtD
Fosphenytoin—Nausea—Fludarabine—lymphatic system cancer	0.000634	0.00141	CcSEcCtD
Fosphenytoin—Infection—Mitoxantrone—lymphatic system cancer	0.000631	0.0014	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000631	0.0014	CcSEcCtD
Fosphenytoin—Shock—Mitoxantrone—lymphatic system cancer	0.000625	0.00139	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000623	0.00138	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000622	0.00138	CcSEcCtD
Fosphenytoin—Urticaria—Bleomycin—lymphatic system cancer	0.000622	0.00138	CcSEcCtD
Fosphenytoin—Anorexia—Vincristine—lymphatic system cancer	0.000622	0.00138	CcSEcCtD
Fosphenytoin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00062	0.00138	CcSEcCtD
Fosphenytoin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000619	0.00138	CcSEcCtD
Fosphenytoin—Insomnia—Carmustine—lymphatic system cancer	0.000618	0.00137	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000614	0.00137	CcSEcCtD
Fosphenytoin—Paraesthesia—Carmustine—lymphatic system cancer	0.000614	0.00136	CcSEcCtD
Fosphenytoin—Mood swings—Methotrexate—lymphatic system cancer	0.00061	0.00136	CcSEcCtD
Fosphenytoin—Hypotension—Vincristine—lymphatic system cancer	0.00061	0.00136	CcSEcCtD
Fosphenytoin—Dyspnoea—Carmustine—lymphatic system cancer	0.000609	0.00136	CcSEcCtD
Fosphenytoin—Somnolence—Carmustine—lymphatic system cancer	0.000607	0.00135	CcSEcCtD
Fosphenytoin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000606	0.00135	CcSEcCtD
Fosphenytoin—Ataxia—Methotrexate—lymphatic system cancer	0.000606	0.00135	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000595	0.00132	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000594	0.00132	CcSEcCtD
Fosphenytoin—Decreased appetite—Carmustine—lymphatic system cancer	0.000594	0.00132	CcSEcCtD
Fosphenytoin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000594	0.00132	CcSEcCtD
Fosphenytoin—Insomnia—Vincristine—lymphatic system cancer	0.00059	0.00131	CcSEcCtD
Fosphenytoin—Paraesthesia—Vincristine—lymphatic system cancer	0.000586	0.0013	CcSEcCtD
Fosphenytoin—Constipation—Carmustine—lymphatic system cancer	0.000584	0.0013	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000579	0.00129	CcSEcCtD
Fosphenytoin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00057	0.00127	CcSEcCtD
Fosphenytoin—Decreased appetite—Vincristine—lymphatic system cancer	0.000567	0.00126	CcSEcCtD
Fosphenytoin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000566	0.00126	CcSEcCtD
Fosphenytoin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000565	0.00126	CcSEcCtD
Fosphenytoin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000563	0.00125	CcSEcCtD
Fosphenytoin—Asthenia—Bleomycin—lymphatic system cancer	0.000562	0.00125	CcSEcCtD
Fosphenytoin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000559	0.00124	CcSEcCtD
Fosphenytoin—Constipation—Vincristine—lymphatic system cancer	0.000558	0.00124	CcSEcCtD
Fosphenytoin—Asthma—Methotrexate—lymphatic system cancer	0.000557	0.00124	CcSEcCtD
Fosphenytoin—Pruritus—Bleomycin—lymphatic system cancer	0.000554	0.00123	CcSEcCtD
Fosphenytoin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000552	0.00123	CcSEcCtD
Fosphenytoin—Constipation—Mitoxantrone—lymphatic system cancer	0.000543	0.00121	CcSEcCtD
Fosphenytoin—Body temperature increased—Carmustine—lymphatic system cancer	0.00054	0.0012	CcSEcCtD
Fosphenytoin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000524	0.00116	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—lymphatic system cancer	0.00052	0.00116	CcSEcCtD
Fosphenytoin—Body temperature increased—Vincristine—lymphatic system cancer	0.000516	0.00115	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000508	0.00113	CcSEcCtD
Fosphenytoin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000505	0.00112	CcSEcCtD
Fosphenytoin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000502	0.00112	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—lymphatic system cancer	0.000499	0.00111	CcSEcCtD
Fosphenytoin—Vomiting—Bleomycin—lymphatic system cancer	0.000498	0.00111	CcSEcCtD
Fosphenytoin—Rash—Bleomycin—lymphatic system cancer	0.000494	0.0011	CcSEcCtD
Fosphenytoin—Dermatitis—Bleomycin—lymphatic system cancer	0.000493	0.0011	CcSEcCtD
Fosphenytoin—Asthenia—Carmustine—lymphatic system cancer	0.00049	0.00109	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—lymphatic system cancer	0.000488	0.00109	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000482	0.00107	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—lymphatic system cancer	0.000476	0.00106	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—lymphatic system cancer	0.000468	0.00104	CcSEcCtD
Fosphenytoin—Asthenia—Vincristine—lymphatic system cancer	0.000468	0.00104	CcSEcCtD
Fosphenytoin—Diarrhoea—Carmustine—lymphatic system cancer	0.000468	0.00104	CcSEcCtD
Fosphenytoin—Nausea—Bleomycin—lymphatic system cancer	0.000465	0.00103	CcSEcCtD
Fosphenytoin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000456	0.00101	CcSEcCtD
Fosphenytoin—Dizziness—Carmustine—lymphatic system cancer	0.000452	0.00101	CcSEcCtD
Fosphenytoin—Diarrhoea—Vincristine—lymphatic system cancer	0.000446	0.000993	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000442	0.000984	CcSEcCtD
Fosphenytoin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000435	0.000967	CcSEcCtD
Fosphenytoin—Vomiting—Carmustine—lymphatic system cancer	0.000434	0.000966	CcSEcCtD
Fosphenytoin—Dizziness—Vincristine—lymphatic system cancer	0.000431	0.00096	CcSEcCtD
Fosphenytoin—Rash—Carmustine—lymphatic system cancer	0.000431	0.000958	CcSEcCtD
Fosphenytoin—Dermatitis—Carmustine—lymphatic system cancer	0.00043	0.000958	CcSEcCtD
Fosphenytoin—Headache—Carmustine—lymphatic system cancer	0.000428	0.000952	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—lymphatic system cancer	0.000415	0.000924	CcSEcCtD
Fosphenytoin—Vomiting—Vincristine—lymphatic system cancer	0.000415	0.000923	CcSEcCtD
Fosphenytoin—Rash—Vincristine—lymphatic system cancer	0.000411	0.000915	CcSEcCtD
Fosphenytoin—Dermatitis—Vincristine—lymphatic system cancer	0.000411	0.000914	CcSEcCtD
Fosphenytoin—Headache—Vincristine—lymphatic system cancer	0.000409	0.000909	CcSEcCtD
Fosphenytoin—Nausea—Carmustine—lymphatic system cancer	0.000406	0.000903	CcSEcCtD
Fosphenytoin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000404	0.000898	CcSEcCtD
Fosphenytoin—Rash—Mitoxantrone—lymphatic system cancer	0.000401	0.000891	CcSEcCtD
Fosphenytoin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0004	0.00089	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—lymphatic system cancer	0.0004	0.000889	CcSEcCtD
Fosphenytoin—Headache—Mitoxantrone—lymphatic system cancer	0.000398	0.000885	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—lymphatic system cancer	0.000387	0.000862	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—lymphatic system cancer	0.00038	0.000845	CcSEcCtD
Fosphenytoin—Nausea—Mitoxantrone—lymphatic system cancer	0.000377	0.000839	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—lymphatic system cancer	0.000375	0.000834	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00036	0.0008	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—lymphatic system cancer	0.000358	0.000797	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—lymphatic system cancer	0.00035	0.000778	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—lymphatic system cancer	0.000348	0.000775	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—lymphatic system cancer	0.000347	0.000772	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—lymphatic system cancer	0.000338	0.000753	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—lymphatic system cancer	0.000336	0.000747	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—lymphatic system cancer	0.00033	0.000734	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—lymphatic system cancer	0.00033	0.000734	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—lymphatic system cancer	0.000326	0.000726	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—lymphatic system cancer	0.000319	0.00071	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000317	0.000704	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—lymphatic system cancer	0.000314	0.000699	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00031	0.000689	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000306	0.000681	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—lymphatic system cancer	0.000302	0.000671	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—lymphatic system cancer	0.000296	0.000658	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000288	0.000641	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—lymphatic system cancer	0.000286	0.000637	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000284	0.000632	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000282	0.000628	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—lymphatic system cancer	0.000281	0.000626	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000279	0.00062	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000275	0.000612	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000261	0.00058	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—lymphatic system cancer	0.000251	0.000559	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—lymphatic system cancer	0.00025	0.000557	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—lymphatic system cancer	0.000227	0.000505	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—lymphatic system cancer	0.000224	0.000498	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000217	0.000482	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—lymphatic system cancer	0.000209	0.000466	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—lymphatic system cancer	0.000201	0.000448	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—lymphatic system cancer	0.0002	0.000444	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—lymphatic system cancer	0.000199	0.000444	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—lymphatic system cancer	0.000198	0.000441	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—lymphatic system cancer	0.000188	0.000418	CcSEcCtD
